July 14, 2022 10:44 AM EDT

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Hal Barron’s anti-aging biotech has added Vir Biotechnology CSO Herbert “Skip” Virgin to its ranks. At the Rick Klausner-founded Altos Labs, Virgin will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Sign up to read this article for free.

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

GSK's Zejula-Jemperli combo in ovarian cancer hits primary endpoint, misses on overall survival

Exclusive: Florida cancer biotech raises $100M Series A

Califf, on his way out at FDA, predicts agency tug-of-war between Ramaswamy and RFK Jr.

Vir CSO de­part­ing next month to be Al­tos CMO; Bob Dug­gan’s Sum­mit Ther­a­peu­tics and the FDA try to make head­way

Senior Reporter

News Reporter

Sign up to read this article for free.

more like this

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway